This trial is conducted in Europe. The aim of this trial is to assess satisfaction with growth hormone treatment in children of both sexes born small for gestational age and who are receiving growth hormone treatment.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
5
Unnamed facility
Lyon, France
Satisfaction/preference with the method of treatment assesses by means of a satisfaction questionnaire and a standard questionnaire of preference
Time frame: after 3 months of treatment
Clinical (adverse events)
Biological (fasting glucose, fasting insulin, liver enzymes)
Tolerance of the treatment
Compliance
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.